Gossamer Bio Competitors and Similar CompaniesClear all
ImmPACT-Bio's competitors and similar companies include Foghorn Therapeutics.
 ImmPACT-Bio ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy. |  Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors. | |
Founding Date | Founding Date 2017 | Founding Date 2016 |
Type | Type Private | Type Public |
Tags | ||
Locations | Locations Camarillo, US HQ Rishon Le Tsiyon, IL | Locations Cambridge, US HQ Cambridge, US |
Employees | Employees 845% decrease | Employees 1123% decrease |
Funding | ||
Total funding raised | Total funding raised $ 18m | Total funding raised $ 50m |
For sources of this data, please see the company profile
View Company Profiles
Foghorn Therapeutics
HQ
Cambridge, US
Employees
112↓ 3% decrease
Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
View company